Gensight Biologics SA

Research Gensight Biologics SA (SIGHT) on Bullrun: market cap EUR 18.90M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSIGHT
• ExchangePA
• CountryFrance
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 18.90M
• Financial periodFY2025
• RevenueEUR 1.00K
• Revenue growth-99.9%
• Net income-EUR 12.04M
• Free cash flow-EUR 9.17M

Valuation Snapshot

latest market cap is EUR 18.90M.

About Gensight Biologics SA

GenSight Biologics S.A., a clinical-stage biotechnology company, discovers, develops, and commercializes novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms.

Frequently asked questions

What is Gensight Biologics SA's market cap?

Gensight Biologics SA's market capitalization is EUR 18.90M.

What does Gensight Biologics SA do?

GenSight Biologics S.A., a clinical-stage biotechnology company, discovers, develops, and commercializes novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.